A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis
A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis
The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to 36 months double-blind administration of study intervention compared to placebo in male and female participants with nrSPMS (aged 18 to 60 years at the time of enrollment). People diagnosed with nrSPMS are eligible for enrollment as long as they meet all the inclusion criteria and none of the exclusion criteria. Study details include:
Inclusion Criteria:
Exclusion Criteria:
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Berkeley, California 94705, United States
Irvine, California 92697, United States
La Jolla, California 92037, United States
Los Angeles, California 90027, United States
Newport Beach, California 92663, United States
Palo Alto, California 94304, United States
West Hollywood, California 90048, United States
Aurora, Colorado 80045, United States
New Haven, Connecticut 06510, United States
Washington D.C., District of Columbia 20007, United States
Clearwater, Florida 33761, United States
Gainesville, Florida 32608, United States
Orlando, Florida 32806, United States
Alexandria, Louisiana 71301, United States
New Orleans, Louisiana 70121, United States
Baltimore, Maryland 21201, United States
Foxborough, Massachusetts 02035, United States
Worcester, Massachusetts 01655, United States
Farmington Hills, Michigan 48334, United States
Owosso, Michigan 48867, United States
Golden Valley, Minnesota 55422, United States
Minneapolis, Minnesota 55455, United States
Plymouth, Minnesota 55446, United States
Las Vegas, Nevada 89106, United States
New York, New York 10029, United States
New York, New York 10032, United States
Charlotte, North Carolina 28210, United States
Winston-Salem, North Carolina 27103, United States
Oklahoma City, Oklahoma 73104, United States
Hershey, Pennsylvania 17033, United States
Nashville, Tennessee 37215, United States
Dallas, Texas 75243, United States
Plano, Texas 75024, United States
Sherman, Texas 75092, United States
Fairfax, Virginia 22031, United States
Milwaukee, Wisconsin 53226, United States
Saint Leonards, New South Wales 2065, Australia
Vitória, Espírito Santo 29055-450, Brazil
Salvador, Estado de Bahia 41820-020, Brazil
Brasília, Federal District 70200-730, Brazil
Belo Horizonte, Minas Gerais 30150-320, Brazil
Curitiba, Paraná 81210-310, Brazil
Joyo-Shi, 610-0113, Japan
Gwent, Blaenau Gwent NP20 2UB, United Kingdom